Havrdova E, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Relapsing Multiple Sclerosis in the OPERA I and OPERA II Trials. EAN 2017, PR1092.
MS-patiënten hebben geen verhoogde kans op COVID-19
nov 2020 | Multipele Sclerose